|
|
|
|
VIROLOGICAL AND CLINICAL OUTCOMES OF PATIENTS WITH
HDV-RELATED COMPENSATED CIRRHOSIS TREATED WITH BULEVIRTIDE MONOTHERAPY:
THE RETROSPECTIVE MULTICENTER EUROPEAN STUDY (SAVE-D)
|
|
|
EASL 2023 June 21-24 Vienna
E. Degasperi1, MP. Anolli1, V. De Ledinghen2, S. Metivier3, M. Jachs4, T. Reiberger4, G. D'Offizi5, C. Dietz-Fricke6, G. Papatheodoridis7, MR. Brunetto8, G. Verucchi9, A. Ciancio10, F. Zoulim11, A. Mangia12, MN. Hilleret13, TA. Santantonio14, N. Coppola15, A. Pellicelli16, B. Roche17, X. Causse18, L. D'Alteroche19, J. Dumortier20, N. Ganne21, F. Heluwaert22, I. Ollivier23, A. Loglio24, M. Vigaṇ25, A. Federico26, F. Pileri27, M. Maracci28, M. Tonnini29, JP. Arpurt30, K. Barange31, E. Billaud32, S. Pol33, A. Gervais34, A. Minello35, I. Rosa36, M. Puoti37, P. Lampertico1,38
|
|
|
|
|
|
|